Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if patients with melancholic bipolar II depression
are more responsive to lamotrigine than patients with non-melancholic bipolar II depression.
To do this, the investigators will re-analyze a previous clinical trial that evaluated
lamotrigine as a treatment for bipolar II depression (GSK-SCA100223; NCT00274677).